Comparative Effects of Four Brief Breathwork and Mindfulness Interventions on Anxiety and Psychological Flexibility: A 4-Arm RCT (BREATH-4)
2. Juni 2026 aktualisiert von: Isaac Carmona-Rincón, Valencian International University (VIU)
Effect of Brief Breathwork and Mindfulness Interventions on Anxiety, Psychological Flexibility and Physiological Variables in Spanish-Speaking University Students: a Four-Arm Randomized Controlled Trial
This four-arm, single-blind randomized controlled trial examines the effects of four brief daily 5-minute practices over 28 days on psychological flexibility and physiological variables in Spanish-speaking adults.
Participants will be randomly assigned to one of four groups: Box Breathing, Cyclic Sighing, Mindfulness focused on exhalation with the syllable "AH", or Conscious Cyclic Sighing.
Outcomes include state and trait anxiety (STAI), positive and negative affect (PANAS), psychological flexibility (MPFI-24, Psy-Flex), and physiological variables (heart rate, respiratory rate, heart rate variability).
Assessments are conducted at baseline, daily during the 28-day intervention, at post-intervention (day 31), and at 2-month follow-up.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Studientyp
Interventionell
Einschreibung (Geschätzt)
240
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Isaac Carmona-Rincón, PhD
- Telefonnummer: +34 618 187 325
- E-Mail: isaac.carmona@professor.universidadviu.com
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Age between 18 and 65 years (inclusive)
- Native Spanish speaker or fluent in Spanish (sufficient to understand audio instructions and complete psychometric questionnaires)
- Stable internet access and an electronic device (smartphone, tablet, or computer)
- Ability to provide informed consent and commitment to the 31-day protocol and 2-month follow-up
Exclusion Criteria:
- Active diagnosis of severe or chronic respiratory disease that prevents safe performance of breathing exercises (e.g., advanced COPD, severe uncontrolled asthma, cystic fibrosis)
- Current diagnosis of severe psychiatric disorder (e.g., psychotic spectrum disorders, acute-phase bipolar disorder, severe major depression with suicidal risk)
- Any acute medical condition contraindicated for voluntary alteration of breathing patterns
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Box Breathing
Daily 5-minute box breathing with individualized timing based on a CO2 tolerance test.
Participants perform a maximal exhale and record the duration; this determines their personal inhale/hold/exhale/hold intervals (3-4s, 5-6s, or 8-10s).
Equal-phase cyclic breathing with exclusive focus on mechanical control and counting.
|
Individualized box breathing based on CO2 tolerance test.
Participants perform a maximal exhale and record the duration (CO2 discard time) to determine their personal cycle interval: 3-4s (0-20s discard), 5-6s (25-45s discard), or 8-10s (50-75s+ discard).
Equal-phase cycles of inhale/hold/exhale/hold repeated for 5 minutes daily.
Focus on mechanical breath control only.
|
|
Experimental: Cyclic Sighing
Daily 5-minute cyclic sighing.
Participants inhale slowly through the nose, then take a second shorter nasal inhale to maximally fill the lungs, followed by a slow, complete oral exhalation.
This double-inhale/long-exhale pattern is repeated continuously for 5 minutes.
No mindfulness or attentional instructions are given.
|
Double nasal inhalation (slow deep inhale + short top-up inhale to maximal lung capacity) followed by slow complete oral exhalation.
Repeated continuously for 5 minutes daily.
No attentional instructions.
|
|
Experimental: Mindfulness AH Exhalation
Daily 5-minute focused-attention mindfulness practice.
Participants sit or lie down, close their eyes, and direct attention to the forehead region between the eyes.
On each exhale, they softly vocalize the syllable "AH" aloud (gentle, unforced audible sound).
When distracted, they use the internal label "thinking-thinking" and redirect attention to the breath and then to the forehead region.
Practice continues for 5 minutes.
|
Focused-attention practice with eyes closed.
Attention directed to forehead region between the eyes.
Each exhalation accompanied by soft audible vocalization of syllable "AH".
Distractions managed with internal label "thinking-thinking" followed by attention redirection.
Practiced daily for 5 minutes.
|
|
Experimental: Mindful Cyclic Sighing
Daily 5-minute hybrid practice combining cyclic sighing mechanics with mindfulness instructions.
Participants inhale slowly through the nose, take a second shorter nasal inhale to maximally fill the lungs, then exhale slowly while softly vocalizing the syllable "AH" aloud (gentle, unforced).
Attention is directed to the breath and the sensation of release during exhalation.
When distracted, participants use the internal label "thinking-thinking" and redirect attention back to the breath.
Practice continues for 5 minutes.
|
Hybrid practice: double nasal inhalation (cyclic sighing mechanics) combined with slow exhalation vocalized as soft audible "AH".
Mindfulness instructions include attention to breath sensations and use of "thinking-thinking" label upon distraction.
Practiced daily for 5 minutes.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
State Anxiety (STAI-E)
Zeitfenster: Baseline (Day 0), daily pre- and post-practice (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
State anxiety measured with the State-Trait Anxiety Inventory - State subscale (STAI-E).
20 items rated on a 4-point Likert scale (0-3).
Higher scores indicate greater anxiety.
Spanish validated version (Guillen-Riquelme & Buela-Casal, 2011).
|
Baseline (Day 0), daily pre- and post-practice (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Positive and Negative Affect (PANAS)
Zeitfenster: Baseline (Day 0), daily pre- and post-practice (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
Positive and negative affect measured with the Positive and Negative Affect Schedule (PANAS).
20 items rated on a 5-point Likert scale.
Two subscales: Positive Affect (PA) and Negative Affect (NA).
Spanish validated version (Lopez-Gomez et al., 2015).
|
Baseline (Day 0), daily pre- and post-practice (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
|
Psychological Flexibility (MPFI-24)
Zeitfenster: Baseline (Day 0), post-intervention (Day 31), and 2-month follow-up
|
Multidimensional psychological flexibility and inflexibility measured with the Multidimensional Psychological Flexibility Inventory short form (MPFI-24). 24 items rated on a 6-point Likert scale assessing 12 Hexaflex processes.
Spanish validated version (Navarrete et al., 2024).
|
Baseline (Day 0), post-intervention (Day 31), and 2-month follow-up
|
|
Psychological Flexibility (Psy-Flex)
Zeitfenster: Baseline (Day 0), daily (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
Unified psychological flexibility measured with the Psy-Flex scale.
6 items rated on a 5-point Likert scale.
A modified daily version will be used during the intervention period.
Spanish validated version (Navarrete et al., 2024).
|
Baseline (Day 0), daily (Days 1-28), post-intervention (Day 31), and 2-month follow-up
|
|
Trait Anxiety (STAI-R)
Zeitfenster: Baseline (Day 0), post-intervention (Day 31), and 2-month follow-up
|
Trait anxiety measured with the State-Trait Anxiety Inventory - Trait subscale (STAI-R).
20 items rated on a 4-point Likert scale (0-3).
Higher scores indicate greater trait anxiety.
Spanish validated version (Guillen-Riquelme & Buela-Casal, 2011).
|
Baseline (Day 0), post-intervention (Day 31), and 2-month follow-up
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Resting Heart Rate (RHR)
Zeitfenster: Daily (Days 1-28)
|
Resting heart rate in beats per minute (bpm) obtained from participants' personal wearable devices (smartwatch/fitness tracker).
Change calculated as the slope of a linear regression fitted to daily values over the 28-day period.
|
Daily (Days 1-28)
|
|
Heart Rate Variability (HRV)
Zeitfenster: Daily (Days 1-28)
|
Heart rate variability obtained from participants' personal wearable devices during deep sleep.
Change calculated as the slope of a linear regression fitted to daily values over the 28-day period.
Only available for participants with compatible devices.
|
Daily (Days 1-28)
|
|
Respiratory Rate (RR)
Zeitfenster: Daily (Days 1-28)
|
Respiratory rate in breaths per minute obtained from participants' personal wearable devices.
Change calculated as the slope of a linear regression fitted to daily values over the 28-day period.
Only available for participants with compatible devices.
|
Daily (Days 1-28)
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Ermittler
- Hauptermittler: Isaac Carmona-Rincón, PhD, Valencian International University (VIU)
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Allgemeine Veröffentlichungen
- Balban MY, Neri E, Kogon MM, Weed L, Nouriani B, Jo B, Holl G, Zeitzer JM, Spiegel D, Huberman AD. Brief structured respiration practices enhance mood and reduce physiological arousal. Cell Rep Med. 2023 Jan 17;4(1):100895. doi: 10.1016/j.xcrm.2022.100895. Epub 2023 Jan 10.
- Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne DR, Farmer AJ, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegfried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson DJ, Vohra S, White IR, Hrobjartsson A. SPIRIT 2025 statement: updated guideline for protocols of randomized trials. Nat Med. 2025 Jun;31(6):1784-1792. doi: 10.1038/s41591-025-03668-w. Epub 2025 Apr 29.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
1. Januar 2027
Primärer Abschluss (Geschätzt)
1. März 2027
Studienabschluss (Geschätzt)
1. Mai 2027
Studienanmeldedaten
Zuerst eingereicht
27. Mai 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
27. Mai 2026
Zuerst gepostet (Tatsächlich)
2. Juni 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
4. Juni 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
2. Juni 2026
Zuletzt verifiziert
1. Juni 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- VIU-BREATH-RCT-2026
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
JA
Beschreibung des IPD-Plans
Anonymized individual participant data (IPD) and the data dictionary will be made available upon reasonable request to the principal investigator (isaac.carmona@professor.universidadviu.com).
Requests will be evaluated on a case-by-case basis.
IPD-Sharing-Zeitrahmen
Beginning 6 months after publication of primary results, available for 5 years
IPD-Sharing-Zugriffskriterien
Researchers who provide a methodologically sound proposal.
Data shared under a data sharing agreement ensuring confidentiality and appropriate use.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ANALYTIC_CODE
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .